Skip to main
GENE
GENE logo

Genetic Technologies (GENE) Market Capitalization Overview

Market Cap: $34.06M as of Aug 1, 2025

$34.06M
Past Month$0.00 (0.00%)
As of Aug 1, 2025, Genetic Technologies (GENE) has a market capitalization of $34.06M. Over the past 30 days, its market cap has increased by 0%, while in the last 12 months, it has increased by 446.77%.

Market capitalization represents the total value of Genetic Technologies as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Genetic Technologies (GENE) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Genetic Technologies (GENE) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Genetic Technologies (GENE) Market Cap History

DateMarket CapChange
Aug 1, 2025$34.06M0.00%
Jul 1, 2025$34.06M0.00%
Jun 2, 2025$34.06M+451.00%
May 1, 2025$6.19M-0.77%
Apr 1, 2025$6.23M0.00%
Mar 3, 2025$6.23M0.00%
Feb 3, 2025$6.23M0.00%
Jan 2, 2025$6.23M0.00%

Genetic Technologies (GENE) End of Year Market Cap History

DateMarket CapChange
2025$34.06M+446.77%
2024$6.23M+1,248.95%
2023$461.70K-99.35%
2022$71.57M-50.51%
2021$144.61M-41.66%
2020$247.86M

FAQs About Genetic Technologies (GENE) Market Cap

As of Aug 1, 2025, the market capitalization of Genetic Technologies (GENE) is $34.06M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Genetic Technologies’s market capitalization has increased by 0.0000%, changing from $34.06M to $34.06M as of Aug 1, 2025.

In the last 3 months, Genetic Technologies’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Genetic Technologies’s market capitalization increased from $461.70K in January to $6.23M in December, reflecting a 1,248.95% change.

In the past five years, Genetic Technologies (GENE) has had a compound annual growth rate (CAGR) of -52.13% in market capitalization. This means its market cap has shrunk at an average rate of -52.13% per year.

Genetic Technologies (GENE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.